<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJPM</journal-id><journal-title-group><journal-title>Open Journal of Preventive Medicine</journal-title></journal-title-group><issn pub-type="epub">2162-2477</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojpm.2015.53011</article-id><article-id pub-id-type="publisher-id">OJPM-54633</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Lifestyle, Biological Risk Markers, Morbidity and Mortality in a Cohort of Men 33 - 42 Years Old at Baseline, after 24-Year Follow-Up of a Primary Health Care Intervention
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>ars-Göran</surname><given-names>Persson</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hans</surname><given-names>Lingfors</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mats</surname><given-names>Nilsson</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sigvard</surname><given-names>Mölstad</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Department of Clinical Sciences, General Practice, Lund University, Malm&amp;amp;ouml, Sweden</addr-line></aff><aff id="aff2"><addr-line>Futurum County Council of J&amp;amp;oumlnk&amp;amp;oumlping, J&amp;amp;oumlnk&amp;amp;oumlping, Sweden</addr-line></aff><aff id="aff1"><addr-line>Health Care Centre of Habo and Unit for Research and Development in Primary Health Care, Futurum, J&amp;amp;oumlnk&amp;amp;oumlping, Sweden</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>Lars-goran.persson@rjl.se(AP)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>03</month><year>2015</year></pub-date><volume>05</volume><issue>03</issue><fpage>92</fpage><lpage>102</lpage><history><date date-type="received"><day>6</day>	<month>February</month>	<year>2015</year></date><date date-type="rev-recd"><day>accepted</day>	<month>10</month>	<year>March</year>	</date><date date-type="accepted"><day>13</day>	<month>March</month>	<year>2015</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Objective: To study changes in lifestyle and biological risk markers in a 24-year follow-up study, and occurrences of cardiovascular diseases (CVD), cancer and total mortality from official registers. Design: A 24-year follow-up survey and register study of a cohort of men 33 - 42 years old, examined with a health profile at baseline. With the health profile based on lifestyle, biological risk markers, self-rated mental stress and mental health, the men were separated in different risk groups. Setting: Primary health care center of Habo in Sweden. Subjects: All 757 men, 33 - 42 years old, and living in the community of Habo in Sweden in 1985. Main Outcome Measures: Lifestyle, biological risk markers, morbidity from CVD and cancer, and total mortality. Results: Smoking and physical activity decreased during follow-up time while alcohol consumption increased. Biological risk markers, except diastolic blood pressure, deteriorated significantly with age. Based on three- lifestyle groups, 16 % of the men had a more favorable lifestyle and 19% had a less favorable life-style at follow-up compared with baseline. The men, who had been classified as high-risk, based on the health profile at baseline, had a significantly higher incidence of CVD and cancer in the register study compared to men in a low-risk group. The baseline non-participant group had a significantly higher incidence of CVD and a higher mortality compared to the low-risk group. Conclusion: A health profile with a combination of lifestyle factors and biological risk markers can already at the age of 33 - 42 years predict incidence of CVD and cancer on group level among men after 24 years.
 
</p></abstract><kwd-group><kwd>Lifestyle</kwd><kwd> Primary Health Care</kwd><kwd> Health Dialogue</kwd><kwd> Primary Prevention</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Cardiovascular disease (CVD) is the most common cause of total mortality and premature death (before 75 years of age) in Sweden as well as in other Western countries [<xref ref-type="bibr" rid="scirp.54633-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.54633-ref2">2</xref>] . However during the period 1997 up to 2012 premature mortality in myocardial infarction has decreased with approximately 50 % in Sweden and most western countries [<xref ref-type="bibr" rid="scirp.54633-ref3">3</xref>] . According to the INTERHEART study, more than 90% of the risk for acute myocardial infarction could be explained by nine modifiable risk factors, most of them being lifestyle factors [<xref ref-type="bibr" rid="scirp.54633-ref4">4</xref>] . The same factors in addition to cardiac disease were associated to 90% of stroke [<xref ref-type="bibr" rid="scirp.54633-ref5">5</xref>] . Lifestyle is also related to risk for cancer [<xref ref-type="bibr" rid="scirp.54633-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.54633-ref7">7</xref>] . In a Swedish study non-smoking, moderate physical activity and minor alcohol consumption together with four healthy dietary habits could identify 60-year-old men and women with substantially lower risk for CVD and death [<xref ref-type="bibr" rid="scirp.54633-ref8">8</xref>] .</p><p>Some kind of global risk assessment is recommended to estimate the risk for future death in CVD. SCORE (Systematic Coronary Risk Evaluation) is one such risk assessment system, developed by the European Society of Cardiology and modified for use in Sweden [<xref ref-type="bibr" rid="scirp.54633-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.54633-ref10">10</xref>] .</p><p>Another kind of risk assessment tool, a pedagogic health profile, was developed and used in a primary prevention programme for men, 33 - 42 years of age, in the community of Habo in Sweden [<xref ref-type="bibr" rid="scirp.54633-ref11">11</xref>] . Each of 10 risk factors considered being most important for CVD and cancer was graded in 4 or 5 levels. This health profile was used in a health dialogue with a specially trained nurse. In that study a rather thorough examination of the non- participants was done [<xref ref-type="bibr" rid="scirp.54633-ref11">11</xref>] .</p><p>An improved health profile called “Health Curve” was later used in a health promotion programme for both men and women 30 and 35 years of age called “Live for Life” where community efforts were combined with a health dialogue with a nurse [<xref ref-type="bibr" rid="scirp.54633-ref12">12</xref>] . In the Health Curve dietary habits concerning fat and fiber intake were measured using a pedagogic food frequency questionnaire [<xref ref-type="bibr" rid="scirp.54633-ref13">13</xref>] .</p><p>Rather few studies concerning cohorts of men with a follow-up time of more than 20 years have been published. The study of British doctors, the Whitehall study and the Oslo study are such examples [<xref ref-type="bibr" rid="scirp.54633-ref14">14</xref>] - [<xref ref-type="bibr" rid="scirp.54633-ref16">16</xref>] . The 50-year follow-up of the male British doctors showed a progressive decrease in mortality rates among non-smokers in relation to continuous smokers, and that smoking cessation in different ages could add years to life expectancy [<xref ref-type="bibr" rid="scirp.54633-ref14">14</xref>] . On group level the continuous smokers lost 10 years of life. In the Whitehall study with 38-year follow-up time, there was a risk core based on smoking, diabetes, employment grade, blood pressure, serum cholesterol, and Body Mass Index (BMI) Men in the highest 5% risk score had a 15 year shorter life expectancy compared with those in the lowest 5% risk score [<xref ref-type="bibr" rid="scirp.54633-ref15">15</xref>] . The Oslo study was a primary prevention intervention study of men focused on lifestyle, especially smoking and dietary habits. The 28-year follow-up showed a decrease of leisure time physical activity (LTPA), and that LTPA had an independent predictive association with metabolic syndrome [<xref ref-type="bibr" rid="scirp.54633-ref16">16</xref>] .</p><p>In studies with long-term follow-up the study population is generally 40 years and older at baseline. There are some examples of studies where the study population is younger than 40 years at baseline [<xref ref-type="bibr" rid="scirp.54633-ref17">17</xref>] - [<xref ref-type="bibr" rid="scirp.54633-ref19">19</xref>] . The 21-year follow-up of the Cardiovascular Risk in Young Finns Study showed an increase in BMI, serum triglycerides and a decrease in blood pressure and serum cholesterol [<xref ref-type="bibr" rid="scirp.54633-ref17">17</xref>] . The men in Chicago Heart Association Detection Project in Industry study were 18 to 39 years at baseline [<xref ref-type="bibr" rid="scirp.54633-ref18">18</xref>] . In this study blood pressure above normal was significantly related to increased mortality due to CVD and all causes. The men in three large cohorts study were also 18 to 39 years at baseline [<xref ref-type="bibr" rid="scirp.54633-ref19">19</xref>] . The results from this study could show a graded relationship of serum cholesterol to long- term risk of CVD and all-cause mortality.</p><p>To our knowledge no studies on a cohort of men as young as in our study have been organized and carried out in primary care with a follow-up time of more than 20 years.</p><p>This 24-year follow-up survey and register study was done on all men 33 - 42 years old at baseline in the community of Habo in Sweden.</p><p>There are four aims of this study:</p><p>・ To study if a long-term follow-up of men in a rather young age group at baseline, can be organized and carried out in primary health care with a high participation rate.</p><p>・ To measure long-time changes, after approximately 24 years of follow-up, in lifestyle and biological risk markers for men taking part in the primary prevention programme in the community of Habo between 1985 and 1987.</p><p>・ To study the association between food habits and a healthy lifestyle concerning physical activity, smoking and alcohol consumption, and the association between self-rated health and the different risk groups.</p><p>・ To study morbidity from CVD, cancer and total mortality, on defined high- and low risk groups and non- participants in the whole baseline cohort of 757 men.</p></sec><sec id="s2"><title>2. Methods</title><sec id="s2_1"><title>2.1. Baseline Survey</title><p>All 757 men in the community of Habo aged 33 - 42 years in 1985 were invited to a health examination and a health dialogue with a specially trained nurse [<xref ref-type="bibr" rid="scirp.54633-ref11">11</xref>] . The health examination was done during the years 1985-1987. A pedagogic health profile, with 10 risk factors considered being most important for CVD and cancer were classified in 4 or 5 levels, was used during this health dialogue <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>Explanations</p><p>Heredity death: Highest risk point for father or mother registered (except for accidents or infections).</p><p>LTPA: 1 means regular hard physical training and competition, 4 means physically inactive leisure time [<xref ref-type="bibr" rid="scirp.54633-ref20">20</xref>] .</p><p>Mental stress: Visual analogue scale, mm (0 - 100).</p><p>Mental health: According to judgement by nurse. 1 means good mental health, 4 means need of group therapy with muscular relaxation and 5 means need for individual contact with a doctor or a psychologist.</p><p>Arterial blood pressure: Highest risk point for systolic or diastolic blood pressure registered. Different values for men under 40 years or ≥40 years old.</p><p>The intention with the health profile was that the men should get a better understanding of the risk factors and the relation between the risk factors. At baseline the 652 men (participation rate 86%) who attended were grouped</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Health profile showing limits for classification into different risk groups (risk points)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Risk faktors studied</th><th align="center" valign="middle"  colspan="5"  >Risk points</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >5</td></tr><tr><td align="center" valign="middle" >Age (yrs) at death of father</td><td align="center" valign="middle" >≥95</td><td align="center" valign="middle" >70 - 94</td><td align="center" valign="middle" >60 - 69</td><td align="center" valign="middle" >50 - 59</td><td align="center" valign="middle" >&lt;50</td></tr><tr><td align="center" valign="middle" >Age (yrs) at death of mother:</td><td align="center" valign="middle" >≥95</td><td align="center" valign="middle" >75 - 94</td><td align="center" valign="middle" >65 - 74</td><td align="center" valign="middle" >55 - 64</td><td align="center" valign="middle" >&lt;55</td></tr><tr><td align="center" valign="middle" >Number of diabetics among parents or siblings</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >≥2</td></tr><tr><td align="center" valign="middle" >Use of alcohol (g per week)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1 - 49</td><td align="center" valign="middle" >50 - 109</td><td align="center" valign="middle" >110 - 249</td><td align="center" valign="middle" >≥250</td></tr><tr><td align="center" valign="middle" >Smoking (cig/day)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >Ex. smoker</td><td align="center" valign="middle" >1 - 14</td><td align="center" valign="middle" >15 - 24</td><td align="center" valign="middle" >≥25</td></tr><tr><td align="center" valign="middle" >LTPA (self-estimation)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Mental stress (self-estimation)</td><td align="center" valign="middle" >&lt;40</td><td align="center" valign="middle" >40-69</td><td align="center" valign="middle" >70-89</td><td align="center" valign="middle" >≥90</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Mental health (estimation by nurse)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >5</td></tr><tr><td align="center" valign="middle" >BMI (kg/m&#178;)</td><td align="center" valign="middle" >&lt;20</td><td align="center" valign="middle" >20 - 24</td><td align="center" valign="middle" >25 - 29</td><td align="center" valign="middle" >30 - 39</td><td align="center" valign="middle" >≥40</td></tr><tr><td align="center" valign="middle" >Blood pressure (mmHg) &lt; 40 years</td><td align="center" valign="middle" >≤140/&lt;85</td><td align="center" valign="middle" >&gt;140/&gt;85</td><td align="center" valign="middle" >&gt;155/&gt;90</td><td align="center" valign="middle" >&gt;160/&gt;95</td><td align="center" valign="middle" >&gt;170/&gt;105</td></tr><tr><td align="center" valign="middle" >Bloodpressure (mmHg) ≥ 40 years</td><td align="center" valign="middle" >≤150/&lt;90</td><td align="center" valign="middle" >&gt;150/&gt;90</td><td align="center" valign="middle" >&gt;160/&gt;95</td><td align="center" valign="middle" >&gt;170/&gt;95</td><td align="center" valign="middle" >&gt;180/&gt;115</td></tr><tr><td align="center" valign="middle" >Serum cholesterol (mmol/l)</td><td align="center" valign="middle" >&lt;4.6</td><td align="center" valign="middle" >4.6 - 5.9</td><td align="center" valign="middle" >6.0 - 7.7</td><td align="center" valign="middle" >7.8 - 9.5</td><td align="center" valign="middle" >≥9.6</td></tr></tbody></table></table-wrap><p>into a high-risk and a low-risk group depending of risk points in the health profile. The risk factors used for this grading were three lifestyle factors smoking; alcohol consumption and LTPA, the biological risk markers BMI, blood pressure and serum cholesterol, as well as self-estimated mental stress and mental health. Family risk factors were not used in this grading.</p><p>The classification of the high-risk group was based on two criteria:</p><p>1) All men with at least one risk factor with risk point 4 or 5 except smoking and LTPA. 2) All men with at least 4 factors with risk point 3. The rest were classified as low-risk group. With these criteria 292 men were classified as high-risk group and 360 men as low-risk group. All 292 men in the high-risk group were advised to see a doctor for further discussion about the risk factors and how to lower these. The doctor decided on clinical judgment if complementary test and pharmacological treatment were to be recommended.</p><p>Participants were also grouped according to lifestyle summarized risk points in the health profile for smoking, LTPA and alcohol consumption. In the baseline examination there were 115 men with a favorable lifestyle (3 - 5 risk points), 270 men in the middle group (6 - 8 risk points) and 96 men in the group with least favorable lifestyle (9 - 14 risk points). None in the healthy lifestyle group was a smoker at baseline.</p><p>Special intervention programs for men with elevated risk factors were carried out in the primary health care center and concerning physical inactivity in cooperation with local clubs. Altogether 418 of the 652 men who attended the health dialogue were recommended some kind of preventive measure. An oral glucose tolerance test was done on all 170 men, who reported a family history of diabetes and/or had a BMI ≥ 27 [<xref ref-type="bibr" rid="scirp.54633-ref21">21</xref>] .</p><p>Intervention programs in the health care center were smoking cessation groups and dietary education in groups. More details about the grading of the health profile, questionnaire, intervention programme, anthropometric measurements and blood tests have been described earlier [<xref ref-type="bibr" rid="scirp.54633-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.54633-ref22">22</xref>] . Men in the high-risk group, who had been to the consultation with the doctor, were also invited to a 1-year follow-up, where 161 men attended.</p></sec><sec id="s2_2"><title>2.2. Follow-Up Survey</title><p>A new health dialogue and examination of the men was carried out during 2009-2010 after a mean follow-up time of 24 years. Due to lack of financial and personnel resources, a selection had to be made. Only those who were still living in the community of Habo or in the neighboring communities were invited to the new health examination. From the baseline high-risk group, all those who attended the 1-year follow-up (141 men) were invited, as were 155 men (every second on the list) from the low-risk group.</p><p>Those who were not invited and those who declined to participate in the new health examination were sent the same health and food frequency questionnaires [<xref ref-type="bibr" rid="scirp.54633-ref13">13</xref>] as those who accepted the invitation and attended. They were asked to measure body weight, height, waist and hip circumference at home after an illustrated instruction. The invitations were sent from Statistics Sweden in order to get correct addresses. A flow chart shows the different groups in the baseline and follow-up examinations <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p><sec id="s2_2_1"><title>2.2.1. Questionnaire</title><p>The questions in the new questionnaire used in the follow-up study were to a great extent the same as in the baseline questionnaire. A new food frequency questionnaire, measuring the intake of saturated and trans fats and fiber, which had been used in the “Live for life” health promotion programme, was added [<xref ref-type="bibr" rid="scirp.54633-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.54633-ref13">13</xref>] . The new health questionnaire included questions about lifestyle, psychosocial exposure, self-rated health, mental stress as well as own and family history of cardiovascular disease, hypertension and diabetes. The participants were also asked to specify which regular medication they were using.</p></sec><sec id="s2_2_2"><title>2.2.2. Examinations</title><p>The anthropometric measurements and peak expiratory flow (PEF) were done in the same way as in the initial health examination [<xref ref-type="bibr" rid="scirp.54633-ref11">11</xref>] . Blood samples, taken in the seated position with a minimal stasis, were sent to and analyzed in the clinical chemistry laboratory in the county hospital of J&#246;nk&#246;ping. Serum cholesterol, triglycerides, S-HDL-cholesterol, and P-glucose were analyzed with an enzymatic method using the instrument ADVIA-1800 from Siemens. S-LDL cholesterol was calculated according to Friedewalds formula.</p></sec><sec id="s2_2_3"><title>2.2.3. Health Dialogue</title><p>All men attending the examination had a health dialogue with a specially trained nurse. The main issue was how to</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Flow chart showing the different groups in the baseline and follow-up examinations</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/2-1340421x6.png"/></fig><p>improve lifestyle in a patient centered way. The men were also given a short brochure about healthy lifestyle and its positive influence on health, diseases and life expectancy. A doctor studied the questionnaires and blood tests and decided if complementary tests were indicated. A letter was sent to all men about the results of the measurement and blood tests and with further advice about lifestyle, and complementary blood tests.</p></sec></sec><sec id="s2_3"><title>2.3. Comparisons Made between Baseline and Follow-Up Surveys</title><p>・ Separate lifestyle factors smoking, alcohol consumption and LTPA.</p><p>・ Combination of lifestyle factors in groups.</p><p>・ Biological risk markers weight, BMI, waist and hip circumferences, waist to hip ratio (WHR), systolic and diastolic blood pressure, serum lipids, blood glucose and PEF.</p></sec><sec id="s2_4"><title>2.4. Register Study</title><p>All males who developed CVD, cancer or died were grouped into the high or low-risk groups of participants and non-participants respectively from the baseline study in 1985-1987 (N = 757). Data were gathered from health-care registers at the Swedish National Board of Health and Welfare. Data from these registers were available up to 2010. ICD-9 diagnoses from 1987-1996 were 410, 431, 432, 434-36. ICD-10 diagnoses from 1997 were I21, I22, I61, I63, I64, G45 and FN. All cancer diagnoses were grouped together. Two groups were formed: Those with at least one CVD diagnose, or cancer diagnoses and those without such diagnose.</p></sec><sec id="s2_5"><title>2.5. Statistical Methods</title><p>Differences between continuous variables like biological risk markers were tested with paired or unpaired t-test. Lifestyle variables were tested with sign test, Wilcoxon and Kruskal-Wallis test. Changes in lifestyle risk points were analyzed with a rank-invariant non-parametric method [<xref ref-type="bibr" rid="scirp.54633-ref23">23</xref>] . Self-rated health was analysed in relation to lifestyle, for high and low-risk group with Chi-Square test and trends with Mantel-Haenszel Chi-Square test. Suitable statistical software has been used for the analysis.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Participation</title><p>During the new health survey, 108 men from the baseline high-risk group (participation rate 77%), and 137 men from the low-risk group (participation rate 88%) attended. The overall participation rate was 83%. Among those not invited to the health examination, 84 men in the high-risk group and 152 men in the low-risk group responded to the questionnaire (54% and 75% respectively) <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p><p>Overall, 192 men in the baseline high-risk group and 289 men in the low-risk group responded to the questionnaires in the follow-up study.</p></sec><sec id="s3_2"><title>3.2. Lifestyle and Self-Rated Health</title><p>Comparing lifestyle for all men, the time trend shows that smoking had decreased (p &lt; 0.001). Of the 131 men (28%) who were smokers at baseline, 81 had quit. At follow-up 10% were daily smokers. The average alcohol consumption had increased from 12.6 cl/week to 22.1 cl/week (p &lt; 0.001). LTPA had decreased (p &lt; 0.001).</p><p>At baseline 92 men (48%) were smokers in the high-risk group and 39 men (13%) in the low-risk group. At follow-up 37 men (19%) were smokers in the high-risk group and 14 men (5%) smokers in the low-risk group. The alcohol consumption was significantly higher in the high-risk group (28 cl/week compared to 18 cl/week). LTPA was higher in the low-risk group, but there was no statistically significant difference.</p><p>An Analysis was done if there had been a shift between the three lifestyle groups from baseline to follow-up <xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p><p>This analyze showed that several men had changed lifestyle risk group and moved from a less favorable to a more favorable group and vice versa. Seventy-five men (16%) had improved their lifestyle from baseline and shifted to a more favorable lifestyle group. Ninety-fourmen (19%) had shifted to a less favorable lifestyle group, while 312 men (65%) belonged to the same lifestyle group booth at follow-up and baseline.</p><p>A healthy lifestyle concerning smoking, LTPA and alcohol consumption was also significantly associated (p &lt; 0.001) with better food habits concerning fat and fiber intake measured with the food frequency questionnaire [<xref ref-type="bibr" rid="scirp.54633-ref13">13</xref>] .</p><p>Self-rated health is an important predictor for future morbidity and mortality. In the questionnaire there was a question where the participants could classify their perceived health into five different levels from excellent to bad. The 192 men in the high-risk group at follow-up estimated their health less favorable than men in the low-risk</p><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Relation between summarized lifestyle risk points during baseline and follow-up examinations [<xref ref-type="bibr" rid="scirp.54633-ref23">23</xref>] </title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/2-1340421x7.png"/></fig><fig id="fig3"  position="float"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> Summarized risk points for lifestyle (smoking, LTPA and alcohol consumption) for baseline and follow-up, number of men in the lifestyle groups and how individuals have changed between risk groups</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/2-1340421x8.png"/></fig><p>group (p &lt; 0.001). There was also a significant trend (p &lt; 0.01) at follow-up for those exhibiting a more favorable lifestyle to estimate their health to be better compared with those with a less favorable lifestyle.</p></sec><sec id="s3_3"><title>3.3. Biological Risk Markers</title><p>The baseline and follow-up variables for biological risk markers were compared for the whole group of participants and questionnaire responders <xref ref-type="table" rid="table2">Table 2</xref>.</p><p>Nurses did anthropometric measurements on the participants in the follow-up survey, and from those who were not invited there were self-reported values in the questionnaires. With the exception of diastolic blood pressure, which was significantly lower during follow-up, all other measurements had deteriorated.</p><p>Follow-up survey variables for baseline low-risk and high-risk groups were compared <xref ref-type="table" rid="table3">Table 3</xref>.</p><p>In the baseline high-risk group most of the biological risk markers were significantly higher at the follow-up than in the low-risk group except for serum cholesterol and PEF. Medication for high serum cholesterol was used by 19% in the high-risk group and by 9% in the low-risk group.</p></sec><sec id="s3_4"><title>3.4. Morbidity and Mortality</title><p>There were no significant differences between the three different baseline lifestyle groups concerning questionnaire reported hypertension, diabetes, cardiovascular diseases or cancer at follow-up. The baseline high-risk group reported significantly more cancer, hypertension and diabetes than the baseline low-risk group at follow-up.</p><p>In the registers from the Swedish National Board of Health and Welfare there were significantly more CVD among the baseline high-risk and non-participant groups than in the low-risk group <xref ref-type="table" rid="table4">Table 4</xref>.</p><p>The total number of cancer was higher in the baseline high-risk group than in the low-risk group. The mortality rate was significantly higher in the baseline non-participant group in comparison with the low-risk group. Almost 7% of the whole cohort had died during follow-up time.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>The overall participation rate of 83% of those who were invited to a new health dialogue and health examination was high. In the 28-year follow-up of the Oslo study the participation was 62% [<xref ref-type="bibr" rid="scirp.54633-ref16">16</xref>] . The men in the Oslo study were 40 - 49 years old at baseline. Only men living in Oslo and Akershus were invited to follow-up. It is comparable to our study where only men still living in Habo and neighboring communities were invited.</p><p>The most positive change in lifestyle factors was smoking cessation with a decrease from 27% to 10%. The decreasing proportion of smokers is similar to the national Swedish trend and figures from Statistics Sweden, although the prevalence of 10% daily smokers at follow-up in our study is lower. In Sweden in 1985 36% of men in age group 36 - 40 years were daily smokers, and in 2010-2011 18% of men in age group 55 - 64 years were daily smokers. In comparison with the initial examination, alcohol consumption had increased from a rather low level and LTPA had decreased. Self-rated health has in several studies been a good predictor for future morbidity and mortality [<xref ref-type="bibr" rid="scirp.54633-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.54633-ref25">25</xref>] . In our study the low-risk group and those with favorable lifestyle estimated their health more positively.</p><p>The biological risk factors, except for diastolic blood pressure had deteriorated significantly for the entire co-</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Comparisons of biological risk markers at baseline and follow-up for all men in the follow-up survey</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  rowspan="2"  >N</th><th align="center" valign="middle"  colspan="2"  >Baseline</th><th align="center" valign="middle"  colspan="2"  >Follow-up</th><th align="center" valign="middle"  rowspan="2"  >Significance</th></tr></thead><tr><td align="center" valign="middle" >Mean</td><td align="center" valign="middle" >SD</td><td align="center" valign="middle" >Mean</td><td align="center" valign="middle" >SD</td></tr><tr><td align="center" valign="middle" >Weight (kg)</td><td align="center" valign="middle" >477</td><td align="center" valign="middle" >77.96</td><td align="center" valign="middle" >9.90</td><td align="center" valign="middle" >85.17</td><td align="center" valign="middle" >12.13</td><td align="center" valign="middle" >***</td></tr><tr><td align="center" valign="middle" >BMI (kg/m&#178;)</td><td align="center" valign="middle" >477</td><td align="center" valign="middle" >24.37</td><td align="center" valign="middle" >2.73</td><td align="center" valign="middle" >26.96</td><td align="center" valign="middle" >3.48</td><td align="center" valign="middle" >***</td></tr><tr><td align="center" valign="middle" >Waist (cm)</td><td align="center" valign="middle" >423</td><td align="center" valign="middle" >90.03</td><td align="center" valign="middle" >7.57</td><td align="center" valign="middle" >99.35</td><td align="center" valign="middle" >9.64</td><td align="center" valign="middle" >***</td></tr><tr><td align="center" valign="middle" >Hip (cm)</td><td align="center" valign="middle" >423</td><td align="center" valign="middle" >100.96</td><td align="center" valign="middle" >5.44</td><td align="center" valign="middle" >103.61</td><td align="center" valign="middle" >6.38</td><td align="center" valign="middle" >***</td></tr><tr><td align="center" valign="middle" >WHR</td><td align="center" valign="middle" >423</td><td align="center" valign="middle" >0.89</td><td align="center" valign="middle" >0.04</td><td align="center" valign="middle" >0.96</td><td align="center" valign="middle" >0.06</td><td align="center" valign="middle" >***</td></tr><tr><td align="center" valign="middle" >Systolicbloodpressure (mmHg)</td><td align="center" valign="middle" >245</td><td align="center" valign="middle" >135.37</td><td align="center" valign="middle" >11.96</td><td align="center" valign="middle" >144.96</td><td align="center" valign="middle" >16.88</td><td align="center" valign="middle" >***</td></tr><tr><td align="center" valign="middle" >Diatolicbloodpressure (mmHg)</td><td align="center" valign="middle" >245</td><td align="center" valign="middle" >87.15</td><td align="center" valign="middle" >8.11</td><td align="center" valign="middle" >85.41</td><td align="center" valign="middle" >8.89</td><td align="center" valign="middle" >**</td></tr><tr><td align="center" valign="middle" >Serum cholesterol (mmol/l)</td><td align="center" valign="middle" >245</td><td align="center" valign="middle" >5.38</td><td align="center" valign="middle" >1.08</td><td align="center" valign="middle" >5.83</td><td align="center" valign="middle" >1.08</td><td align="center" valign="middle" >***</td></tr><tr><td align="center" valign="middle" >Serum triglycerides (mmol/l)</td><td align="center" valign="middle" >245</td><td align="center" valign="middle" >1.82</td><td align="center" valign="middle" >1.25</td><td align="center" valign="middle" >2.26</td><td align="center" valign="middle" >1.34</td><td align="center" valign="middle" >***</td></tr><tr><td align="center" valign="middle" >Blood glucose (mmol/l)</td><td align="center" valign="middle" >245</td><td align="center" valign="middle" >5.28</td><td align="center" valign="middle" >1.03</td><td align="center" valign="middle" >5.94</td><td align="center" valign="middle" >1.71</td><td align="center" valign="middle" >***</td></tr><tr><td align="center" valign="middle" >PEF</td><td align="center" valign="middle" >205</td><td align="center" valign="middle" >612.3</td><td align="center" valign="middle" >73.64</td><td align="center" valign="middle" >557.4</td><td align="center" valign="middle" >77.22</td><td align="center" valign="middle" >***</td></tr></tbody></table></table-wrap><p><sup>**</sup>p &lt; 0.01, <sup>***</sup>p &lt; 0.001 follow-up values compared with baseline values. Registrations for waist, hip, WHR, PEF were not complete during the first examination. Some questionnaire responders did not report their anthropometric measurements. During follow-up only those who took part in the health examination had measurements for blood pressure and serum lipids.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Comparison of biological risk markers for baseline low- and high-risk groups at follow-up</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  colspan="3"  >Low-risk group</th><th align="center" valign="middle"  colspan="3"  >High-risk group</th><th align="center" valign="middle"  rowspan="2"  >Significance</th></tr></thead><tr><td align="center" valign="middle" >N</td><td align="center" valign="middle" >Mean</td><td align="center" valign="middle" >SD</td><td align="center" valign="middle" >N</td><td align="center" valign="middle" >Mean</td><td align="center" valign="middle" >SD</td></tr><tr><td align="center" valign="middle" >Weight (kg)</td><td align="center" valign="middle" >286</td><td align="center" valign="middle" >83.06</td><td align="center" valign="middle" >10.18</td><td align="center" valign="middle" >191</td><td align="center" valign="middle" >88.34</td><td align="center" valign="middle" >14.01</td><td align="center" valign="middle" >***</td></tr><tr><td align="center" valign="middle" >BMI (kg/m<sup>2</sup>)</td><td align="center" valign="middle" >286</td><td align="center" valign="middle" >26.25</td><td align="center" valign="middle" >2.83</td><td align="center" valign="middle" >191</td><td align="center" valign="middle" >28.03</td><td align="center" valign="middle" >4.06</td><td align="center" valign="middle" >***</td></tr><tr><td align="center" valign="middle" >Waist (cm)</td><td align="center" valign="middle" >284</td><td align="center" valign="middle" >97.43</td><td align="center" valign="middle" >8.24</td><td align="center" valign="middle" >190</td><td align="center" valign="middle" >102.48</td><td align="center" valign="middle" >10.87</td><td align="center" valign="middle" >***</td></tr><tr><td align="center" valign="middle" >Hip (cm)</td><td align="center" valign="middle" >284</td><td align="center" valign="middle" >102.75</td><td align="center" valign="middle" >5.74</td><td align="center" valign="middle" >190</td><td align="center" valign="middle" >104.91</td><td align="center" valign="middle" >7.21</td><td align="center" valign="middle" >***</td></tr><tr><td align="center" valign="middle" >WHR</td><td align="center" valign="middle" >284</td><td align="center" valign="middle" >0.95</td><td align="center" valign="middle" >0.06</td><td align="center" valign="middle" >190</td><td align="center" valign="middle" >0.98</td><td align="center" valign="middle" >0.06</td><td align="center" valign="middle" >***</td></tr><tr><td align="center" valign="middle" >Systolicblood pressure (mmHg)</td><td align="center" valign="middle" >137</td><td align="center" valign="middle" >142.89</td><td align="center" valign="middle" >16.23</td><td align="center" valign="middle" >108</td><td align="center" valign="middle" >147.58</td><td align="center" valign="middle" >17.38</td><td align="center" valign="middle" >*</td></tr><tr><td align="center" valign="middle" >Diatolicblood pressure (mmHg)</td><td align="center" valign="middle" >137</td><td align="center" valign="middle" >84.39</td><td align="center" valign="middle" >8.83</td><td align="center" valign="middle" >108</td><td align="center" valign="middle" >86.69</td><td align="center" valign="middle" >8.85</td><td align="center" valign="middle" >*</td></tr><tr><td align="center" valign="middle" >Serum cholesterol (mmol/l)</td><td align="center" valign="middle" >137</td><td align="center" valign="middle" >5.87</td><td align="center" valign="middle" >1.12</td><td align="center" valign="middle" >108</td><td align="center" valign="middle" >5.77</td><td align="center" valign="middle" >1.03</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Serum triglycerides (mmol/l)</td><td align="center" valign="middle" >137</td><td align="center" valign="middle" >2.06</td><td align="center" valign="middle" >1.01</td><td align="center" valign="middle" >108</td><td align="center" valign="middle" >2.52</td><td align="center" valign="middle" >1.63</td><td align="center" valign="middle" >**</td></tr><tr><td align="center" valign="middle" >Bloodglucose (mmol/l)</td><td align="center" valign="middle" >137</td><td align="center" valign="middle" >5.74</td><td align="center" valign="middle" >1.19</td><td align="center" valign="middle" >108</td><td align="center" valign="middle" >6.19</td><td align="center" valign="middle" >2.18</td><td align="center" valign="middle" >*</td></tr><tr><td align="center" valign="middle" >PEF</td><td align="center" valign="middle" >136</td><td align="center" valign="middle" >560.48</td><td align="center" valign="middle" >76.44</td><td align="center" valign="middle" >107</td><td align="center" valign="middle" >548.60</td><td align="center" valign="middle" >81.84</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p><sup>*</sup>p &lt; 0.05, <sup>**</sup>p &lt; 0.01, <sup>***</sup>p &lt; 0.001 values for high-risk group compared with low-risk group. Registrations for waist, hip, WHR, PEF were not complete during the first examination. Some questionnaire responders did not report their anthropometric measurements. During follow-up only those who took part in the health examination had measurements for blood pressure and serum lipids.</p><p>hort and especially for the high-risk group. The fact that serum cholesterol was not higher in the high-risk group could be explained by differences in lipid lowering medication. Medication for high serum cholesterol was used by 19% in the high-risk group and by 9% in the low-risk group. The change and deterioration of most biological risk markers is similar to men in the Whitehall study [<xref ref-type="bibr" rid="scirp.54633-ref26">26</xref>] . A study in Gothenburg of risk factors in a group of men 50 years old and another group of men 60 years old showed impaired anthropometric data, blood pressure, but not serum lipids among the older men [<xref ref-type="bibr" rid="scirp.54633-ref27">27</xref>] .</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Numbers of CVD, cancer and total mortality in the baseline low-risk, high-risk and nonparticipant groups, together with Odds ratio and confidence intervals. Comparisons were made with baseline low-risk group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Risk group</th><th align="center" valign="middle" >N</th><th align="center" valign="middle" >Number of CVD</th><th align="center" valign="middle" >Odds ratio</th><th align="center" valign="middle" >CI</th><th align="center" valign="middle" >Number of cancer</th><th align="center" valign="middle" >Odds ratio</th><th align="center" valign="middle" >CI</th><th align="center" valign="middle" >Number of dead</th><th align="center" valign="middle" >Odds ratio</th><th align="center" valign="middle" >CI</th></tr></thead><tr><td align="center" valign="middle" >Low-risk</td><td align="center" valign="middle" >360</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >1.0</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >1.0</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >1.0</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >High-risk</td><td align="center" valign="middle" >292</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >2.1</td><td align="center" valign="middle" >1.21 - 3.64</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >2.25</td><td align="center" valign="middle" >1.34 - 3.77</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >1.92</td><td align="center" valign="middle" >0.91 - 4.05</td></tr><tr><td align="center" valign="middle" >Non participants</td><td align="center" valign="middle" >105</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >2.14</td><td align="center" valign="middle" >1.03 - 4.42</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >1.5</td><td align="center" valign="middle" >0.44 - 4.83</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >4.44</td><td align="center" valign="middle" >1.97 - 10.06</td></tr></tbody></table></table-wrap><p>The distribution in high-risk and low-risk groups based on the health profile seemed, at group level, to be able to predict a significant higher incidence of CVD and cancer, and a non-significant higher incidence of total mortality, in the high-risk group in comparison with the low-risk group. The baseline non-participant group had a higher incidence of CVD, and a higher mortality than the low-risk group. Other studies have also shown that non-par- ticipants have a higher morbidity and mortality than participants [<xref ref-type="bibr" rid="scirp.54633-ref28">28</xref>] - [<xref ref-type="bibr" rid="scirp.54633-ref30">30</xref>] . In our earlier study of the baseline non- participant group this group could be divided into three different groups [<xref ref-type="bibr" rid="scirp.54633-ref11">11</xref>] . Those men who did not participate because they had already taken part in a similar health examination, those who already had frequent contacts with health care because if different diseases, and those who were not interested [<xref ref-type="bibr" rid="scirp.54633-ref11">11</xref>] . It is reasonable to think that the higher morbidity from CVD and mortality in the non-participant group can be linked primarily to these last two groups.</p><p>In most studies with long term follow-up the study population is 40 years and older at baseline. There are some examples where the study population is younger and single risk factors can predict CVD. In the Chicago Heart Association Detection Project in Industry blood pressure was related to mortality in CVD after 25 years [<xref ref-type="bibr" rid="scirp.54633-ref18">18</xref>] . In a study of three cohorts serum cholesterol had a long time relationship to CVD and all-cause mortality [<xref ref-type="bibr" rid="scirp.54633-ref19">19</xref>] .</p><p>The SCORE-model based on age, gender, serum cholesterol, systolic blood pressure and smoking is designed to predict risk for mortality in CVD in 10 years for people 40 to 65 years [<xref ref-type="bibr" rid="scirp.54633-ref9">9</xref>] . This model was compared with the Framingham risk score and WHO/ISH model in Asian population 40 - 65 years, and was considered suitable to identify high CVD risk [<xref ref-type="bibr" rid="scirp.54633-ref31">31</xref>] . The SCORE-model is also compared to a Swedish consultation-based method without laboratory examinations on a population 40 - 59 years with equal result [<xref ref-type="bibr" rid="scirp.54633-ref32">32</xref>] . An aim for a future study can be to compare our health profile with the SCORE-model.</p><p>To our knowledge there are few examples of health prediction instruments for mortality of both cancer and CVD. The computer based Real Age is one example capable to predict mortality both for cancer and CVD [<xref ref-type="bibr" rid="scirp.54633-ref33">33</xref>] . In Real Age people could register health habits, family history, serum cholesterol, blood pressure and several psychosocial data. The data used in the Real Age register are similar to those in our health profile.</p><p>The strength in our study is the long follow-up time as well as the high participation rate among those who were invited. The limitations are lack of values for blood tests and blood pressures for those who were not invited, who also self-reported their own measurements of weight, height, and waist and hip circumferences. These data were thus not standardized according to the measurements that the nurses performed of the participants at the health care center. In spite of this we consider the self-reported data useful, and can be included in the data analyses. The Real Age register is also based on self-reported data [<xref ref-type="bibr" rid="scirp.54633-ref33">33</xref>] . There is always a risk for participation bias in follow-up studies. The high participation rate in our study and that those who were not invited were sent a postal questionnaire and asked to measure their weight, length, waist and hip circumferences are assumed to reduce the risk for participation bias. Another method to improve participation rate is to offer home visits to non-participants, as was done in the 32-year follow-up of the population study of women in Gothenburg [<xref ref-type="bibr" rid="scirp.54633-ref34">34</xref>] .</p></sec><sec id="s5"><title>5. Conclusion</title><p>In conclusion this study shows that it was possible to organize and carry out a long-term follow-up study, of this at baseline relative young group of men, in primary health care with a high participation rate. The categorization of the participants in high-risk and low-risk groups from values in the health profile could predict the incidence of CVD and cancer after 24 years of follow-up. Concerning lifestyle factors smoking and LTPA had decreased. Alcohol consumption had increased but from a relatively low level. Biological risk markers, except diastolic blood pressure, deteriorated significantly with age.</p></sec><sec id="s6"><title>Acknowledgements</title><p>This study was supported by grants from the Medical Research Council of Southeast Sweden (FORSS) and Futurum County Council of J&#246;nk&#246;ping Sweden.</p></sec><sec id="s7"><title>Ethical Approval</title><p>The study was approved by the Regional Ethical Review Board in Link&#246;ping (Dnr M167-09).</p></sec><sec id="s8"><title>Declaration of Interest</title><p>The authors report no conflict of interest. The authors alone are responsible for the content and writing of the paper.</p></sec><sec id="s9"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.54633-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Sveriges Officiella Statistik. Statistik - H&amp;aumllso- och Sjukvard. D&amp;oumldsorsaker 2008. [Official Statistics of Sweden. Statistics - Health and Medical Care. Causes of Death 2008]. English Summery Stockholm: Socialstyrelsen; 2010.</mixed-citation></ref><ref id="scirp.54633-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">La Vecchia, C., Levi, F., Lucchini, F., et al. (1998) Trends in Mortality from Major Diseases in Europe, 1980-1993. European Journal of Epidemiology, 14, 1-8. http://dx.doi.org/10.1023/A:1007440201137</mixed-citation></ref><ref id="scirp.54633-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">The European Health Report (2012)&lt;sup&gt;OBJ&lt;/sup&gt;Charting the Way to Well-Being: WHO. Regional Office for Europe.</mixed-citation></ref><ref id="scirp.54633-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Yusuf, S., Hawken, S., Ounpuu, S., et al. (2004) Effect of Potentially Modifiable Risk Factors Associated with Myocardial Infarction in 52 Countries (the INTERHEART Study): Case-Control Study. Lancet, 364, 937-952.  
http://dx.doi.org/10.1016/S0140-6736(04)17018-9</mixed-citation></ref><ref id="scirp.54633-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">O’Donnell, M.J., Xavier, D., Liu, L., et al. (2010) Risk Factors for Ischaemic and Intracerebral Haemorrhagic Stroke in 22 Countries (the INTERSTROKE Study): A Case-Control Study. Lancet, 376, 112-123.  
http://dx.doi.org/10.1016/S0140-6736(10)60834-3</mixed-citation></ref><ref id="scirp.54633-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Coyle, Y.M. (2009) Lifestyle, Genes, and Cancer. Methods in Molecular Biology, 472, 25-56.  
http://dx.doi.org/10.1007/978-1-60327-492-0_2</mixed-citation></ref><ref id="scirp.54633-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Khan, N., Afaq, F. and Mukhtar, H. (2010) Lifestyle as Risk Factor for Cancer: Evidence from Human Studies. Cancer Letters, 293, 133-143. http://dx.doi.org/10.1016/j.canlet.2009.12.013</mixed-citation></ref><ref id="scirp.54633-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Carlsson, A.C., Wandell, P.E., Gigante, B., et al. (2013) Seven Modifiable Lifestyle Factors Predict Reduced Risk for Ischemic Cardiovascular Disease and All-Cause Mortality Regardless of Body Mass Index: A Cohort Study. International Journal of Cardiology, 168, 946-952.</mixed-citation></ref><ref id="scirp.54633-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Conroy, R.M., Pyorala, K., Fitzgerald, A.P., et al. (2003) Estimation of Ten-Year Risk of Fatal Cardiovascular Disease in Europe: the SCORE Project. European Heart Journal, 24, 987-1003.  
http://dx.doi.org/10.1016/S0195-668X(03)00114-3</mixed-citation></ref><ref id="scirp.54633-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Wilhelmsen, L., Wedel, H., Conroy, R., et al. (2004) The Swedish SCORE Chart for Cardiovascular Risk. Better Possibilities for Prevention of Cardiovascular Diseases. Lakartidningen, 101, 1798-801.</mixed-citation></ref><ref id="scirp.54633-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Persson, L.G., Lindstr&amp;oumlm, K., Lingfors, H. and Bengtsson, C. (1994) A Study of Men Aged 33-42 in Habo, Sweden with Special Reference to Cardiovascular Risk Factors. Design, Health Profile and Characteristics of Participants and Non-Participants. Scandinavian Journal of Social Medicine, 22, 264-272.</mixed-citation></ref><ref id="scirp.54633-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Persson, L.G., Lindstr&amp;oumlm, K., Lingfors, H., Bengtsson, C. and Lissner, L. (1998) Cardiovascular Risk during Early Adult Life. Risk Markers among Participants in “Live for Life” Health Promotion Programme in Sweden. Journal of Epidemiology &amp; Community Health, 52, 425-432. http://dx.doi.org/10.1136/jech.52.7.425</mixed-citation></ref><ref id="scirp.54633-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Lingfors, H., Lindstr&amp;oumlm, K., Persson, L.G., Bengtsson, C., Lissner, L., Ellegard, L. and Andersson, H.A. (1994) Evaluation of a Pedagogic Dietary Questionnaire Aimed for Health Surveys. Scandinavian Journal of Nutrition, 38, 106- 111.</mixed-citation></ref><ref id="scirp.54633-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Doll, R., Peto, R., Boreham, J. and Sutherland, I. (2004) Mortality in Relation to Smoking: 50 Years’ Observations on Male British Doctors. BMJ, 328, 1519. http://dx.doi.org/10.1136/bmj.38142.554479.AE</mixed-citation></ref><ref id="scirp.54633-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Clarke, R., Emberson, J., Fletcher, A., Breeze, E., Marmot, M. and Shipley, M.J. (2009) Life Expectancy in Relation to Cardiovascular Risk Factors: 38 Year Follow-Up of 19,000 Men in the Whitehall Study. BMJ, 339, b3513. 
http://dx.doi.org/10.1136/bmj.b3513</mixed-citation></ref><ref id="scirp.54633-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Holme, I., Tonstad, S., Sogaard, A.J., Lund Larsen, P.G. and Haheim, L.L. (2007) Leisure Time Physical Activity in Middle Age Predicts the Metabolic Syndrome in Old Age: Results of a 28-Year Follow-Up of Men in the Oslo Study. BMC Public Health, 7, 154. http://dx.doi.org/10.1186/1471-2458-7-154</mixed-citation></ref><ref id="scirp.54633-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Juonala, M., Viikari, J.S., Hutri-Kahonen, N., Pietikainen, M., Jokinen, E., Taittonen, L., et al. (2004) The 21-Year Follow-Up of the Cardiovascular Risk in Young Finns Study: Risk Factor Levels, Secular Trends and East-West Difference. Journal of Internal Medicine, 255, 457-468. http://dx.doi.org/10.1111/j.1365-2796.2004.01308.x</mixed-citation></ref><ref id="scirp.54633-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Miura, K., Daviglus, M.L., Dyer, A.R., Liu, K., Garside, D.B., Stamler, J. and Greenland, P. (2001) Relationship of Blood Pressure to 25-Year Mortality Due to Coronary Heart Disease, Cardiovascular Diseases, and All Causes in Young Adult Men: The Chicago Heart Association Detection Project in Industry. Archives of Internal Medicine, 161, 1501-1508. http://dx.doi.org/10.1001/archinte.161.12.1501</mixed-citation></ref><ref id="scirp.54633-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Stamler, J., Daviglus, M.L., Garside, D.B., Dyer, A.R., Greenland, P. and Neaton, J.D. (2000) Relationship of Baseline Serum Cholesterol Levels in 3 Large Cohorts of Younger Men to Long-Term Coronary, Cardiovascular, and All-Cause Mortality and to Longevity. JAMA, 284, 311-318. http://dx.doi.org/10.1001/jama.284.3.311</mixed-citation></ref><ref id="scirp.54633-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Saltin, B. and Grimby, G. (1968) Physiological Analysis of Middle-Aged and Old Former Athletes. Comparison with Still Active Athletes of the Same Ages. Circulation, 38, 1104-1115. http://dx.doi.org/10.1161/01.CIR.38.6.1104</mixed-citation></ref><ref id="scirp.54633-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Persson, L.G., Lindstr&amp;oumlm, K. and Bengtsson, C. (1994) Oral Glucose Tolerance and Its Relationship to Overweight and Other Cardiovascular Risk Factors in Men Aged 33-42. A Study in the Community of Habo, Sweden. Scandinavian Journal of Primary Health Care, 12, 261-268. http://dx.doi.org/10.3109/02813439409029251</mixed-citation></ref><ref id="scirp.54633-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Persson, L.G., Lindstr&amp;oumlm, K., Lingfors, H. and Bengtsson, C. (1996) Results from an Intervention Programme Dealing with Cardiovascular Risk Factors. Experiences from a Study of Men Aged 33-42 in Habo, Sweden. Scandinavian Journal of Primary Health Care, 14, 184-192. http://dx.doi.org/10.3109/02813439609024175</mixed-citation></ref><ref id="scirp.54633-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Svensson, E. (1998) Ordinal Invariant Measures for Individual and Group Changes in Ordered Categorical Data. Statistics in Medicine, 17, 2923-2936. 
http://dx.doi.org/10.1002/(SICI)1097-0258(19981230)17:24&lt;2923::AID-SIM104&gt;3.0.CO;2-#</mixed-citation></ref><ref id="scirp.54633-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Bopp, M., Braun, J., Gutzwiller, F. and Faeh, D., for the Swiss National Cohort Study Group (2012) Health Risk or Resource? Gradual and Independent Association between Self-Rated Health and Mortality Persists over 30 Years. PLoS ONE, 7, e30795. http://dx.doi.org/10.1371/journal.pone.0030795</mixed-citation></ref><ref id="scirp.54633-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Latham, K. and Peek, C.W. (2013) Self-Rated Health and Morbidity Onset among Late Midlife US Adults. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 68, 107-116. 
http://dx.doi.org/10.1093/geronb/gbs104</mixed-citation></ref><ref id="scirp.54633-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Clarke, R., Breeze, E., Youngman, L., Sherliker, P., Bell, P., Shah, S., et al. (2000) Re-Survey of the Whitehall Study of London Civil Servants: Changes in Risk Factors for Cardiovascular Disease during 29 Years of Follow-Up. Journal of Cardiovascular Risk, 7, 251-257.</mixed-citation></ref><ref id="scirp.54633-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Welin, L., Adlerberth, A., Caidahl, K., Eriksson, H., Hansson, P.-O., Johansson, S., et al. (2008) Prevalence of Cardiovascular Risk Factors and the Metabolic Syndrome in Middle-Aged Men and Women in Gothenburg, Sweden. BMC Public Health, 8, 403. http://dx.doi.org/10.1186/1471-2458-8-403</mixed-citation></ref><ref id="scirp.54633-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Rosengren, A., Wilhelmsen, L., Berglund, G. and Elmfeldt, D. (1987) Non-Participation in a General Population Study of Men, with Special Reference to Social and Alcoholic Problems. Acta Medica Scandinavica, 221, 243-251. 
http://dx.doi.org/10.1111/j.0954-6820.1987.tb00890.x</mixed-citation></ref><ref id="scirp.54633-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Wilhelmsen, L., Ljungberg, S., Wedel, H. and Werk&amp;ouml, L. (1976) A Comparison between Participants and Non-Participants in a Primary Preventive Trial. Journal of Chronic Diseases, 29, 331-339. 
http://dx.doi.org/10.1016/0021-9681(76)90093-X</mixed-citation></ref><ref id="scirp.54633-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Larsen, S.B., Dalton, S.O., Schuz, J., Christensen, J., Overvad, K., Tjonneland, A., et al. (2012) Mortality among Participants and Non-Participants in a Prospective Cohort Study. European Journal of Epidemiology, 27, 837-845. 
http://dx.doi.org/10.1007/s10654-012-9739-x</mixed-citation></ref><ref id="scirp.54633-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Selvarajah, S., Kaur, G., Haniff, J., Cheong, K.C., Hiong, T.G., van der Graaf, Y. and Bots, M.L. (2014) Comparison of the Framingham Risk Score, SCORE and WHO/ISH Cardiovascular Risk Prediction Models in an Asian Population. International Journal of Cardiology, 176, 211-218. http://dx.doi.org/10.1016/j.ijcard.2014.07.066</mixed-citation></ref><ref id="scirp.54633-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Petersson, U., &amp;OUMLstgren, C.J., Brudin, L. and Nilsson, P.M. (2009) A Consultation-Based Method Is Equal to SCORE and an Extensive Laboratory-Based Method in Predicting Risk of Future Cardiovascular Disease. European Journal of Cardiovascular Prevention &amp; Rehabilitation, 16, 536-540. http://dx.doi.org/10.1097/HJR.0b013e32832b1833</mixed-citation></ref><ref id="scirp.54633-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Hobbs, W.R. and Fowler, J.H. (2014) Prediction of Mortality Using On-Line, Self-Reported Health Data: Empirical Test of the Real Age Score. PLoS ONE, 9, e86385. http://dx.doi.org/10.1371/journal.pone.0086385</mixed-citation></ref><ref id="scirp.54633-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Lissner, L., Skoog, I., Andersson, K., Beckman, N., Sundh, V., Waern, M., et al. (2003) Participation Bias in Longitudinal Studies: Experience from the Population Study of Women in Gothenburg, Sweden. Scandinavian Journal of Primary Health Care, 21, 242-247. http://dx.doi.org/10.1080/02813430310003309-1693</mixed-citation></ref></ref-list></back></article>